Drug recall · August 7, 2019
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS recall
Why: cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only, Manufactured by Dr. Reddy's Laboratories Ltd. Bachupally - 500 090 India. Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152. NDC # 0904-6363-61.
- Lots / codes
Lot# M02250 EXP 10/2020.
- Quantity
- 828 100-count unit dose cartons
- Company
- Major Pharmaceuticals, Livonia, MI
- Distribution
- Nationwide in the USA
- Initiated
- April 24, 2019 · N/A
- Classified
- August 1, 2019
- Reported
- August 7, 2019
- Ended
- July 16, 2020
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valproate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.